Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2012

Dec 10, 2012

29777_dirs_2012-12-10_58301c55-6588-4795-97d8-44b7016d2387.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-12-06

Reporting Person: Blaser Brian J (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-06 Common shares without par value M 3000 $46.34 Acquired 82724 Direct
2012-12-06 Common shares without par value M 3800 $44.16 Acquired 86524 Direct
2012-12-06 Common shares without par value M 5700 $53.60 Acquired 92224 Direct
2012-12-06 Common shares without par value M 5800 $55.56 Acquired 98024 Direct
2012-12-06 Common shares without par value M 12800 $54.14 Acquired 110824 Direct
2012-12-06 Common shares without par value M 6467 $54.50 Acquired 117291 Direct
2012-12-06 Common shares without par value M 12667 $48.34 Acquired 129958 Direct
2012-12-06 Common shares without par value M 13867 $46.60 Acquired 143825 Direct
2012-12-06 Common shares without par value S 1300 $64.405 Disposed 142525 Direct
2012-12-06 Common shares without par value S 400 $64.415 Disposed 142125 Direct
2012-12-06 Common shares without par value S 100 $64.4175 Disposed 142025 Direct
2012-12-06 Common shares without par value S 2100 $64.420 Disposed 139925 Direct
2012-12-06 Common shares without par value S 1300 $64.425 Disposed 138625 Direct
2012-12-06 Common shares without par value S 100 $64.4275 Disposed 138525 Direct
2012-12-06 Common shares without par value S 2200 $64.43 Disposed 136325 Direct
2012-12-06 Common shares without par value S 1600 $64.435 Disposed 134725 Direct
2012-12-06 Common shares without par value S 3900 $64.44 Disposed 130825 Direct
2012-12-06 Common shares without par value S 1700 $64.445 Disposed 129125 Direct
2012-12-06 Common shares without par value S 100 $64.4475 Disposed 129025 Direct
2012-12-06 Common shares without par value S 100 $64.449 Disposed 128925 Direct
2012-12-06 Common shares without par value S 3800 $64.45 Disposed 125125 Direct
2012-12-06 Common shares without par value S 1300 $64.455 Disposed 123825 Direct
2012-12-06 Common shares without par value S 2100 $64.46 Disposed 121725 Direct
2012-12-06 Common shares without par value S 500 $64.465 Disposed 121225 Direct
2012-12-06 Common shares without par value S 200 $64.4675 Disposed 121025 Direct
2012-12-06 Common shares without par value S 4600 $64.47 Disposed 116425 Direct
2012-12-06 Common shares without par value S 3900 $64.475 Disposed 112525 Direct
2012-12-06 Common shares without par value S 100 $64.4775 Disposed 112425 Direct
2012-12-06 Common shares without par value S 5247 $64.48 Disposed 107178 Direct
2012-12-06 Common shares without par value S 1100 $64.485 Disposed 106078 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-12-06 Option (right to buy) $46.34 M 3000 Disposed 2015-02-17 Common shares (3000) Direct
2012-12-06 Option (right to buy) $44.16 M 3800 Disposed 2016-02-16 Common shares (3800) Direct
2012-12-06 Option (right to buy) $53.60 M 5700 Disposed 2017-07-19 Common shares (5700) Direct
2012-12-06 Option (right to buy) $55.56 M 5800 Disposed 2018-02-14 Common shares (5800) Direct
2012-12-06 Option (right to buy) $54.14 M 12800 Disposed 2019-02-19 Common shares (12800) Direct
2012-12-06 Option (right to buy) $54.50 M 6467 Disposed 2020-02-18 Common shares (6467) Direct
2012-12-06 Option (right to buy) $48.34 M 12667 Disposed 2020-05-16 Common shares (12667) Direct
2012-12-06 Option (right to buy) $46.60 M 13867 Disposed 2021-02-17 Common shares (13867) Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.